What the research found

Researchers placed 46 normotensive adults on two controlled diets in sequence: one very low in sodium and one high in sodium. They measured proteins shed into urine via extracellular vesicles (small membrane-bound particles released from kidney tubule cells) to assess how different sodium intakes affected kidney transport activity.

When participants ate a low-sodium diet, their bodies activated compensatory mechanisms: renin and aldosterone levels rose, and specific sodium-reabsorbing proteins in the kidney tubules (NCC, ENaC, SGLT2, OXSR1, and Pendrin) appeared in higher concentrations in urinary vesicles. Conversely, proteins involved in calcium and water handling (TRPV5 and AQP2) showed lower concentrations. The high-sodium diet produced the opposite pattern, with these proteins decreasing as sodium conservation became less necessary.

The key methodological point: urinary extracellular vesicles appear to reflect the actual activity state of kidney tubule cells in real time, offering a non-invasive window into how the kidneys are handling electrolytes.

Why it matters for you

If you're tracking blood pressure, electrolytes, or renin-aldosterone-cortisol dynamics as part of your optimisation protocol, this work suggests a potential biomarker you don't currently have access to. Right now, you can measure serum aldosterone, plasma renin activity, and sodium excretion via 24-hour urine collection—but you can't directly see which kidney tubule segments are responding to your dietary sodium intake. Urinary extracellular vesicle profiling might eventually let you do that.

This also contextualises the salt-sensitivity question many MyKine users face: why does one person's blood pressure spike on high sodium while another's doesn't? The study hints that individual differences in how aggressively kidney transporters activate (or fail to activate) during sodium challenges could explain some of that variance. Someone with blunted aldosterone response or dysregulated tubular protein expression might handle sodium differently than the population average.

For now, the practical takeaway is narrower: if you're experimenting with sodium restriction for hypertension management and monitoring aldosterone or renin as biomarkers, this confirms those hormones are genuinely triggering coordinated changes in kidney function, not just circulating idly.

Caveats

• Small, selected sample: 46 healthy adults at risk for hypertension; findings may not generalise to people with existing kidney disease, resistant hypertension, or other comorbidities.
• Short-term intervention: Each diet phase was brief; it's unclear whether these protein changes persist long-term or normalise after weeks.
• Observational mechanistic work: The study describes associations between diet and protein abundance but doesn't prove causation or show clinical outcomes (e.g., blood pressure change, kidney protection).
• Urinary extracellular vesicles are not yet a clinical tool: The methods are research-stage; no commercial lab currently offers this assay as a routine test.